ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack

January 8, 1993

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

NCI-Approved Clinical Trials

April 29, 2005

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978

Concept Approved For New Quality Assurance Center

May 14, 1982

Mammography For Women Under 50 Debated; Cut Of 3-4% Offered As Budget Trimmer

July 23, 1976